Cargando…

Insight on Diagnosis and Treatment From Over a Decade of Research Through the University of Chicago Monogenic Diabetes Registry

Monogenic diabetes is a category of diabetes mellitus caused by a single gene mutation or chromosomal abnormality, usually sub-classified as either neonatal diabetes or maturity-onset diabetes of the young (MODY). Although monogenic diabetes affects up to 3.5% of all patients with diabetes diagnosed...

Descripción completa

Detalles Bibliográficos
Autores principales: Bowden, Tiana L., Letourneau-Freiberg, Lisa R., Kandasamy, Balamurugan, Sanyoura, May, Tian, Persephone, Harris, Anastasia G., Bell, Graeme I., Philipson, Louis H., Naylor, Rochelle N., Greeley, Siri Atma W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629510/
https://www.ncbi.nlm.nih.gov/pubmed/36330312
http://dx.doi.org/10.3389/fcdhc.2021.735548
_version_ 1784823410000396288
author Bowden, Tiana L.
Letourneau-Freiberg, Lisa R.
Kandasamy, Balamurugan
Sanyoura, May
Tian, Persephone
Harris, Anastasia G.
Bell, Graeme I.
Philipson, Louis H.
Naylor, Rochelle N.
Greeley, Siri Atma W.
author_facet Bowden, Tiana L.
Letourneau-Freiberg, Lisa R.
Kandasamy, Balamurugan
Sanyoura, May
Tian, Persephone
Harris, Anastasia G.
Bell, Graeme I.
Philipson, Louis H.
Naylor, Rochelle N.
Greeley, Siri Atma W.
author_sort Bowden, Tiana L.
collection PubMed
description Monogenic diabetes is a category of diabetes mellitus caused by a single gene mutation or chromosomal abnormality, usually sub-classified as either neonatal diabetes or maturity-onset diabetes of the young (MODY). Although monogenic diabetes affects up to 3.5% of all patients with diabetes diagnosed before age 30, misdiagnosis and/or improper treatment occurs frequently. The University of Chicago Monogenic Diabetes Registry, established in 2008, offers insight into the diagnosis, treatment, and natural history of individuals known or suspected to have monogenic diabetes. Those interested in participating in the Registry begin by completing a secure web-based registration form found on our website (http://monogenicdiabetes.uchicago.edu/registry/). Participants are then screened for eligibility and consented either by phone, video call, or in person. Relevant medical and family history is collected at baseline and then annually via surveys through our secure Research Electronic Data Capture (REDCap) database. The University of Chicago Monogenic Diabetes Registry has enrolled over 3800 participants from over 2000 families. Participants represent all 50 states and more than 20 different countries. To date, over 1100 participants have a known genetic cause of diabetes. While many Registry participants reported being referred through their diabetes care provider (54%), a large portion also learned about the Registry through web searching (24%), friends/family (18%), or other sources (13%). Around two-thirds of those with a known genetic cause had research-based genetic testing completed rather than clinical testing due to insurance coverage difficulties. Of those who were found to have monogenic diabetes, significant delays in diagnosis were identified, which highlights the need for increased access to clinical genetic testing covered by insurance companies specifically within the United States. Among genes that cause a MODY phenotype, GCK mutations were the most common (59%) followed by HNF1A mutations (28%), while mutations in KCNJ11 were the most common among genes that cause neonatal diabetes (35%) followed by INS (16%). Over the last decade, improvements in data collection for the University of Chicago Monogenic Diabetes Registry have resulted in increased knowledge of the natural history of monogenic diabetes, as well as a better understanding of the most effective treatments. The University of Chicago Monogenic Diabetes Registry serves as a valuable resource that will continue to provide evidence to support improved clinical care and patient outcomes in monogenic diabetes.
format Online
Article
Text
id pubmed-9629510
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96295102022-11-02 Insight on Diagnosis and Treatment From Over a Decade of Research Through the University of Chicago Monogenic Diabetes Registry Bowden, Tiana L. Letourneau-Freiberg, Lisa R. Kandasamy, Balamurugan Sanyoura, May Tian, Persephone Harris, Anastasia G. Bell, Graeme I. Philipson, Louis H. Naylor, Rochelle N. Greeley, Siri Atma W. Front Clin Diabetes Healthc Clinical Diabetes and Healthcare Monogenic diabetes is a category of diabetes mellitus caused by a single gene mutation or chromosomal abnormality, usually sub-classified as either neonatal diabetes or maturity-onset diabetes of the young (MODY). Although monogenic diabetes affects up to 3.5% of all patients with diabetes diagnosed before age 30, misdiagnosis and/or improper treatment occurs frequently. The University of Chicago Monogenic Diabetes Registry, established in 2008, offers insight into the diagnosis, treatment, and natural history of individuals known or suspected to have monogenic diabetes. Those interested in participating in the Registry begin by completing a secure web-based registration form found on our website (http://monogenicdiabetes.uchicago.edu/registry/). Participants are then screened for eligibility and consented either by phone, video call, or in person. Relevant medical and family history is collected at baseline and then annually via surveys through our secure Research Electronic Data Capture (REDCap) database. The University of Chicago Monogenic Diabetes Registry has enrolled over 3800 participants from over 2000 families. Participants represent all 50 states and more than 20 different countries. To date, over 1100 participants have a known genetic cause of diabetes. While many Registry participants reported being referred through their diabetes care provider (54%), a large portion also learned about the Registry through web searching (24%), friends/family (18%), or other sources (13%). Around two-thirds of those with a known genetic cause had research-based genetic testing completed rather than clinical testing due to insurance coverage difficulties. Of those who were found to have monogenic diabetes, significant delays in diagnosis were identified, which highlights the need for increased access to clinical genetic testing covered by insurance companies specifically within the United States. Among genes that cause a MODY phenotype, GCK mutations were the most common (59%) followed by HNF1A mutations (28%), while mutations in KCNJ11 were the most common among genes that cause neonatal diabetes (35%) followed by INS (16%). Over the last decade, improvements in data collection for the University of Chicago Monogenic Diabetes Registry have resulted in increased knowledge of the natural history of monogenic diabetes, as well as a better understanding of the most effective treatments. The University of Chicago Monogenic Diabetes Registry serves as a valuable resource that will continue to provide evidence to support improved clinical care and patient outcomes in monogenic diabetes. Frontiers Media S.A. 2021-11-05 /pmc/articles/PMC9629510/ /pubmed/36330312 http://dx.doi.org/10.3389/fcdhc.2021.735548 Text en Copyright © 2021 Bowden, Letourneau-Freiberg, Kandasamy, Sanyoura, Tian, Harris, Bell, Philipson, Naylor and Greeley https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Clinical Diabetes and Healthcare
Bowden, Tiana L.
Letourneau-Freiberg, Lisa R.
Kandasamy, Balamurugan
Sanyoura, May
Tian, Persephone
Harris, Anastasia G.
Bell, Graeme I.
Philipson, Louis H.
Naylor, Rochelle N.
Greeley, Siri Atma W.
Insight on Diagnosis and Treatment From Over a Decade of Research Through the University of Chicago Monogenic Diabetes Registry
title Insight on Diagnosis and Treatment From Over a Decade of Research Through the University of Chicago Monogenic Diabetes Registry
title_full Insight on Diagnosis and Treatment From Over a Decade of Research Through the University of Chicago Monogenic Diabetes Registry
title_fullStr Insight on Diagnosis and Treatment From Over a Decade of Research Through the University of Chicago Monogenic Diabetes Registry
title_full_unstemmed Insight on Diagnosis and Treatment From Over a Decade of Research Through the University of Chicago Monogenic Diabetes Registry
title_short Insight on Diagnosis and Treatment From Over a Decade of Research Through the University of Chicago Monogenic Diabetes Registry
title_sort insight on diagnosis and treatment from over a decade of research through the university of chicago monogenic diabetes registry
topic Clinical Diabetes and Healthcare
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629510/
https://www.ncbi.nlm.nih.gov/pubmed/36330312
http://dx.doi.org/10.3389/fcdhc.2021.735548
work_keys_str_mv AT bowdentianal insightondiagnosisandtreatmentfromoveradecadeofresearchthroughtheuniversityofchicagomonogenicdiabetesregistry
AT letourneaufreiberglisar insightondiagnosisandtreatmentfromoveradecadeofresearchthroughtheuniversityofchicagomonogenicdiabetesregistry
AT kandasamybalamurugan insightondiagnosisandtreatmentfromoveradecadeofresearchthroughtheuniversityofchicagomonogenicdiabetesregistry
AT sanyouramay insightondiagnosisandtreatmentfromoveradecadeofresearchthroughtheuniversityofchicagomonogenicdiabetesregistry
AT tianpersephone insightondiagnosisandtreatmentfromoveradecadeofresearchthroughtheuniversityofchicagomonogenicdiabetesregistry
AT harrisanastasiag insightondiagnosisandtreatmentfromoveradecadeofresearchthroughtheuniversityofchicagomonogenicdiabetesregistry
AT bellgraemei insightondiagnosisandtreatmentfromoveradecadeofresearchthroughtheuniversityofchicagomonogenicdiabetesregistry
AT philipsonlouish insightondiagnosisandtreatmentfromoveradecadeofresearchthroughtheuniversityofchicagomonogenicdiabetesregistry
AT naylorrochellen insightondiagnosisandtreatmentfromoveradecadeofresearchthroughtheuniversityofchicagomonogenicdiabetesregistry
AT greeleysiriatmaw insightondiagnosisandtreatmentfromoveradecadeofresearchthroughtheuniversityofchicagomonogenicdiabetesregistry